Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 104253
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104253
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104253
Figure 2 Quantitative analysis of SHOX2, RASSF1A, SEPTIN9, and HOXA9 DNA methylation in cholangiocarcinoma (n = 156) and control (n = 98) specimens.
CCA: Cholangiocarcinoma.
- Citation: Yu J, Liu QC, Lu SY, Wang S, Zhang H. Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring. World J Gastrointest Oncol 2025; 17(4): 104253
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/104253.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.104253